- Publication
- Sep 8, 2015
A synthetic lectin analog for biomimetic disaccharide recognition
Ferrand, et al. Science, 2007, 318, 619-622- Publication
- Sep 8, 2015
Differential estrogen receptor subtype modulators: Assessment of estrogen receptor subtype-binding selectivity and transcription-regulating properties of new cycloalkyl pyrazoles
Alexi, et al. J. Steroid Biochem. Mol. Biol., 2009, 117, 159-167- Publication
- Sep 8, 2015
Amide-based inhibitors of p38′ MAP kinase. Part 1: Discovery of novel N-pyridyl amide lead molecules
Luedtke, et al. Bioorg. Med. Chem. Lett., 2010, 20, 2556-2559- Publication
- Sep 8, 2015
1H-1,2,3-Triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors
Salameh, et al. Bioorg. Med. Chem. Lett., 2010, 18, 5367-5378- Publication
- Sep 8, 2015
MM-GB/SA Rescoring of Docking Poses in Structure-Based Lead Optimization
Guimar’es, et al. J. Chem. Inf. Model., 2008, 48, 958-970- Publication
- Sep 8, 2015
Novel selective human melanocortin-3 receptor ligands: use of the 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one (Aba) scaffold
Ballet, et al. Bioorg. Med. Chem. Lett., 2007, 17, 2492-2498- Publication
- Sep 8, 2015
Thyrotropin-releasing hormone and its receptors–a hypothesis for binding and receptor activation
Engel, et al. Pharmacol. Ther., 2007, 113, 410-419- Publication
- Sep 8, 2015
The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria
Leach, et al. Mol. Cell., 2007, 26, 393-402- Publication
- Sep 8, 2015
Synthesis, biological evaluation and molecular modeling studies of N-6-benzyladenosine analogues as potential anti-toxoplasma agents
Kim, et al. Biochem. Pharmacol., 2007, 73, 1558-1572- Publication
- Sep 8, 2015
Identification of Residues Important for Agonist Recognition and Activation in GPR40
Sum, et al. J. Biol. Chem., 2007, 282, 29248-29255- Publication
- Sep 8, 2015
Minimum structure requirement of immunomodulatory glycolipids for predominant Th2 cytokine induction and the discovery of non-linear phytosphingosine analogs
Toba, et al. Bioorg. Med. Chem. Lett., 2007, 17, 2781-2784- Publication
- Sep 8, 2015
Predicting Enantioselectivity: Computation as an Efficient “Experimental” Tool for Probing Enantioselectivity
Ragusa, et al. Eur. J. Org. Chem., 2006, 16, 3545-3549
Latest insights from Extrapolations blog
With FEP+, “The Experiment is the Limit.”
Over the past century, small molecule drugs have represented the dominant modality in drug research, enabling medical breakthroughs that have saved countless lives.
Tackling Drug Solubility: AbbVie and Schrödinger Collaborate to Advance Accurate Prediction Methods
The complexity and size of drug candidates has grown in recent years as scientists pursue novel targets once considered undruggable.
Blog
Can AlphaFold Models be Used for Structure-Based Drug Design? A Perspective Two Years In
We recently sat down with Edward Miller, Senior Director of Protein Structure Modeling at Schrödinger, to discuss his experience using AlphaFold models for SBDD.
Training & Resources
Online certification courses
Level up your skill set with hands-on, online molecular modeling courses. These self-paced courses cover a range of scientific topics and include access to Schrödinger software and support.
Free learning resources
Learn how to deploy the technology and best practices of Schrödinger software for your project success. Find training resources, tutorials, quick start guides, videos, and more.
Other Resources